Stay updated on Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Sign up to get notified when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.

Latest updates to the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page
- Check3 days agoChange DetectedLocations sections were expanded to include US states, Canadian provinces, and European regions, accompanied by a new revision tag v3.3.3. The prior location blocks associated with v3.3.2 were removed/adjusted to reflect the update.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, which is a minor version change and does not affect study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe notice about government funding and operating status has been removed. The page now presents only the study details and related information, with no changes to the study data or eligibility criteria.SummaryDifference0.2%

- Check53 days agoChange DetectedNo significant changes detected; the study details page content appears unchanged between screenshots.SummaryDifference0.2%

- Check82 days agoChange DetectedImportant updates: added a government funding notice and current operating status for the NIH Clinical Center, and updated the version to v3.2.0 (removing v3.1.0).SummaryDifference3%

- Check89 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.